Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -50.00% | -.--% | -.--% |
2022 | FluoroPharma Medical, Inc. Announces Executive Changes | CI |
2022 | FluoroPharma Medical, Inc. Appoints Frank I Igwealor as CFO | CI |
Sales 2015 | - | Sales 2016 | - | Capitalization | 3.8M 317M |
---|---|---|---|---|---|
Net income 2015 | -3M -250M | Net income 2016 | -2M -167M | EV / Sales 2015 | - |
Net Debt 2015 | 4.19M 350M | Net Debt 2016 | 5.8M 484M | EV / Sales 2016 | - |
P/E ratio 2015 |
-2.41
x | P/E ratio 2016 |
-1.45
x | Employees | 4 |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 99.97% |
1 day | -50.00% | ||
6 months | -50.00% |
Managers | Title | Age | Since |
---|---|---|---|
Ambrose Egbuonu
CEO | Chief Executive Officer | - | 16/22/16 |
Frank Igwealor
DFI | Director of Finance/CFO | 53 | 16/22/16 |
Chairman | 78 | 14/11/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 78 | 14/11/14 | |
William Lewis
BRD | Director/Board Member | 48 | 06/15/06 |
Frank Igwealor
DFI | Director of Finance/CFO | 53 | 16/22/16 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.76K | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- FPMI Stock